Model‐Informed Optimal Dosing of Anti‐CD47 Antibody Using Target‐Mediated Drug Disposition Model

Documenti analoghi

• Predicting lung exposure of intramuscular niclosamide as an antiviral agent: Power‐law based pharmacokinetic modeling
  di: Taeheon Kim, et al.
  Pubblicazione: (2024)
• A Mechanism‐Based Multi‐Level Population PK/PD Model for Potassium‐Competitive Acid Blockers
  di: Woojin Jung, et al.
  Pubblicazione: (2026)
• Predicting the Pharmacokinetics of T‐Cell Engagers as a Function of Target‐Mediated Drug Disposition
  di: Mark Penney, et al.
  Pubblicazione: (2025)
• Population Pharmacokinetic–Pharmacodynamic Modeling of Granulocyte Colony‐Stimulating Factor to Optimize Dosing and Timing for CD34+ Cell Harvesting
  di: Xu Jiang, et al.
  Pubblicazione: (2025)
• Navigating Recent Changes in Dosing Information: Dynamics of FDA‐Approved Monoclonal Antibodies in Post‐Marketing Realities
  di: Nai Lee, et al.
  Pubblicazione: (2025)